North Wales Medical School
- 2024
-
CARiAD research and implementation
Marlise Poolman (Speaker)
10 Apr 2024Activity: Talk or presentation › Invited talk
-
Every failure is a piece of important knowledge". Experiences and insights from re-applying for research funding.
Marlise Poolman (Speaker)
10 Apr 2024Activity: Talk or presentation › Invited talk
- 2023
-
Mobile health interventions to improve adherence to oral anticoagulant treatment: A systematic review
Non Davies (Speaker)
1 Dec 2023Activity: Talk or presentation › Oral presentation
-
Macmillan Professionals Conference
Marlise Poolman (Speaker)
Nov 2023 → …Activity: Participating in or organising an event › Participation in Academic workshop, seminar, course
-
CARer-ADministration of as-needed subcutaneous medication for breakthrough symptoms in people dying at home: accelerating the impact of new practice (CARiAD).
Marlise Poolman (Speaker)
Oct 2023 → …Activity: Talk or presentation › Oral presentation
-
CARer-ADministration of As-needed Subcutaneous Medication for Breakthrough Symptoms in People Dying at Home (CARiAD): Rapid Implementation, Quality Improvement and Accelerating Impact of New Practice.
Marlise Poolman (Speaker)
16 Jun 2023Activity: Talk or presentation › Oral presentation
- 2022
-
BU-IIA Funded Project: Bangor University Antimicrobial Resistance Interest Group: Engagement Project
Emily Holmes (Contributor)
4 May 2022 → 30 Apr 2023Activity: Other
-
BU-IIA Funded Project: VOICES-DDH: Value of information and cost-effectiveness of screening for developmental dysplasia of the hip (DDH)
Catrin Plumpton (Contributor)
1 May 2022 → 30 Apr 2023Activity: Other
-
BU-IIA Funded Project: CARiAD Intervention
Marlise Poolman (Contributor), Julia Hiscock (Contributor), Annie Hendry (Contributor), Clare Wilkinson (Contributor) & Emma Jones (Contributor)
1 Apr 2022 → 31 Mar 2023Activity: Other
-
BU-IIA Funded Project: Drug Target in Pancreatic Cancer
Christopher Staples (Contributor)
1 Apr 2022 → 31 Mar 2023Activity: Other
-
BU-IIA Funded Project: Genotoxicity of nucleoside analogue anti-viral and anti-cancer drugs
Edgar Hartsuiker (Contributor) & Rolf Kraehenbuehl (Contributor)
1 Apr 2022 → 31 Mar 2023Activity: Other